| Target Price | $137.70 |
| Price | $49.88 |
| Potential | 176.06% |
| Number of Estimates | 43 |
| 43 Analysts have issued a price target CoreWeave 2027 . The average CoreWeave target price is $137.70. This is 176.06% higher than the current stock price. The highest price target is $318.15 537.83% , the lowest is $39.39 21.03% . | |
| A rating was issued by 52 analysts: 37 Analysts recommend CoreWeave to buy, 13 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the CoreWeave stock has an average upside potential 2027 of 176.06% . Most analysts recommend the CoreWeave stock at Purchase. |
49 Analysts have issued a sales forecast CoreWeave 2026 . The average CoreWeave sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
40 Analysts have issued an CoreWeave EBITDA forecast 2026. The average CoreWeave EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
47 CoreWeave Analysts have issued a net profit forecast 2026. The average CoreWeave net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Buy
➜
Buy
|
Unchanged | Nov 12 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Nov 12 2026 |
| Macquarie |
Outperform
➜
Outperform
|
Unchanged | Nov 12 2026 |
| DA Davidson |
Neutral
➜
Neutral
|
Unchanged | Nov 11 2026 |
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Nov 11 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Nov 11 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Nov 11 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Argus Research:
Buy
➜
Buy
|
Nov 12 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Nov 12 2026 |
|
Unchanged
Macquarie:
Outperform
➜
Outperform
|
Nov 12 2026 |
|
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
Nov 11 2026 |
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Nov 11 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Nov 11 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Nov 11 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


